The recall was initiated on October 10, 2024, after the discovery of N-nitroso-duloxetine, a nitrosamine impurity, in the medication. Duloxetine, sold under brand names such as Cymbalta, is prescribed ...
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.